Align Technology, Inc. logo

Align Technology, Inc.

ALGN

NASDAQHealthcareMedical - Devices

Previous close

$162.55

+$3.61 · +2.27%

Aug 21, 4:00 PM ET

Pre-market

$163.05

+$0.50 · +0.31%

Aug 24, 7:29 AM ET

ALGN company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Hold

Wait — insufficient conviction to act

Valuation

74

Undervalued

Momentum

53

Neutral

Sentiment

74

Bullish

Risk resilience

51

Elevated Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Align Technology, Inc. is a medical technology enterprise that develops, produces, and markets its leading products: Invisalign transparent dental aligners and iTero digital intraoral scanners, along with related services. These offerings serve a wide range of dental professionals, including orthodontists, general dentists, and those specializing in restorative and cosmetic dentistry. The company's operations are divided into two main business units: "Clear Aligner" and "Scanners and Services." The Clear Aligner segment offers a variety of solutions. Its comprehensive products include the full Invisalign treatment for teenage patients, designed to address complex orthodontic needs such as mandibular advancement, patient compliance tracking, and managing tooth eruption. It also features specialized Invisalign First Phase I and Phase 2 packages for younger children, typically aged seven to ten, who have mixed dentition (a combination of primary and permanent teeth). Beyond these, the segment provides non-comprehensive aligner options like Invisalign moderate, lite, express, and Invisalign Go. Additional non-case products include retention devices, fees for Invisalign training, and sales of ancillary items such as cleaning materials and adjustment tools used by dental practitioners during treatment. The Scanners and Services segment centers around the iTero scanner, a unified hardware platform offering various software applications for both restorative and orthodontic procedures. It supplies specialized restorative software to general dentists, prosthodontists, periodontists, and oral surgeons, as well as distinct software for orthodontists to manage digital patient records, perform diagnoses, and facilitate the fabrication of printed models and retainers. This segment also provides computer-aided design and manufacturing (CAD/CAM) services, along with supplementary products like disposable covers for the scanner wand and iTero models and dies. Furthermore, it includes third-party scanners and digital scan solutions, the Invisalign Outcome Simulator (a chair-side and cloud-based application for the iTero scanner), the Invisalign Progress Assessment tool, and TimeLapse technology, which enables clinicians to compare a patient's historical 3D scans against current data. Align Technology distributes its products worldwide, with a strong presence in the United States, Switzerland, and China. Founded in 1997, the company is headquartered in Tempe, Arizona.

Industry
Medical - Devices
Sector
Healthcare
Headquarters
US
CEO
Joseph Hogan
Listed since
Jan 30, 2001
Employees
20,435

Market position

Day range

Current $162.55

52-week range

Current $162.55

Open
$158.95
Previous close
$158.94
Volume
1.08M
1.06× average
Average volume
1.01M
Average daily volume
Market cap
11.64B USD
Beta
1.65
Market reference 1
50-day average
$174.72
-6.96% below average
200-day average
$169.49
-4.09% below average

Financials

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends81%55%29%3%Gross margin, FY2021: 74.26%Gross margin, FY2022: 70.52%Gross margin, FY2023: 70.08%Gross margin, FY2024: 70.00%Gross margin, FY2025: 68.33%Operating margin, FY2021: 24.70%Operating margin, FY2022: 17.21%Operating margin, FY2023: 16.66%Operating margin, FY2024: 15.19%Operating margin, FY2025: 15.27%Net margin, FY2021: 19.53%Net margin, FY2022: 9.68%Net margin, FY2023: 11.52%Net margin, FY2024: 10.54%Net margin, FY2025: 10.17%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 74.26%. Gross margin FY2022 70.52%. Gross margin FY2023 70.08%. Gross margin FY2024 70.00%. Gross margin FY2025 68.33%. Operating margin FY2021 24.70%. Operating margin FY2022 17.21%. Operating margin FY2023 16.66%. Operating margin FY2024 15.19%. Operating margin FY2025 15.27%. Net margin FY2021 19.53%. Net margin FY2022 9.68%. Net margin FY2023 11.52%. Net margin FY2024 10.54%. Net margin FY2025 10.17%.

Income trends

Revenue

4.03B USD+0.90%

Operating income

616.22M USD+1.41%

Net income

410.35M USD-2.61%
Income trends across reported periods4.4B USD2.93B USD1.46B USD−5.77M USDRevenue, FY2021: 3.95B USDRevenue, FY2022: 3.73B USDRevenue, FY2023: 3.86B USDRevenue, FY2024: 4B USDRevenue, FY2025: 4.03B USDOperating income, FY2021: 976.4M USDOperating income, FY2022: 642.6M USDOperating income, FY2023: 643.34M USDOperating income, FY2024: 607.63M USDOperating income, FY2025: 616.22M USDNet income, FY2021: 772.02M USDNet income, FY2022: 361.57M USDNet income, FY2023: 445.05M USDNet income, FY2024: 421.36M USDNet income, FY2025: 410.35M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 3.95B USD. Revenue FY2022 3.73B USD. Revenue FY2023 3.86B USD. Revenue FY2024 4B USD. Revenue FY2025 4.03B USD. Operating income FY2021 976.4M USD. Operating income FY2022 642.6M USD. Operating income FY2023 643.34M USD. Operating income FY2024 607.63M USD. Operating income FY2025 616.22M USD. Net income FY2021 772.02M USD. Net income FY2022 361.57M USD. Net income FY2023 445.05M USD. Net income FY2024 421.36M USD. Net income FY2025 410.35M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue4.03B USD4B USD3.86B USD3.73B USD3.95B USD
Cost of goods sold1.28B USD1.2B USD1.16B USD1.1B USD1.02B USD
Gross profit2.76B USD2.8B USD2.71B USD2.63B USD2.94B USD
Research and development369.91M USD364.2M USD346.83M USD305.26M USD250.32M USD
Selling, general, and administrative1.76B USD1.76B USD1.7B USD1.67B USD1.71B USD
Operating expenses2.14B USD2.19B USD2.06B USD1.99B USD1.96B USD
Interest income16.05M USD20.22M USD17.26M USD5.37M USD3.1M USD
Depreciation and amortization180.59M USD145.03M USD142.4M USD125.79M USD108.73M USD
Operating income616.22M USD607.63M USD643.34M USD642.6M USD976.4M USD
Net income410.35M USD421.36M USD445.05M USD361.57M USD772.02M USD

Company facts updated Aug 24, 2026.

ALGN peers

ETFs holding ALGN

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research ALGN

research.disclaimer